Torben Lykke Sørensen

Research output

Research output per year 1997 2011 2013 2014 2016 2017 2018 2019 2020

• 104 Journal article
• 6 Comment/debate
• 4 Review
• 2 Conference abstract in journal
• 4 More
  • 2 Letter
  • 1 Book
  • 1 Book chapter

Research output per year

Research output per year

Search results

• 2016

  Monitoring of Diabetic Retinopathy in relation to Bariatric Surgery: a Prospective Observational Study

  Brynskov, T., Laugesen, C. S., Svenningsen, A. L., Floyd, A. K. & Sørensen, T. L., 1 Jun 2016, In: Obesity Surgery. 26, 6, p. 1279-86 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Bariatric Surgery 100%
  • Diabetic Retinopathy 94%
  • Observational Studies 69%
  • Prospective Studies 57%
  • Macular Edema 23%
  20 Citations (Scopus)

• Non-physician delivered intravitreal injection service is feasible and safe: a systematic review

  Rasul, A., Subhi, Y., Sørensen, T. L. & Munch, I. C., May 2016, In: Danish Medical Journal. 63, 5, A5229.

  Research output: Contribution to journal › Review › peer-review

  • Intravitreal Injections 100%
  • Systematic Reviews 62%
  • Nurses 46%
  • Physicians 40%
  • Vitreous Body 28%
  9 Citations (Scopus)

• Physical activity patterns in patients with early and late age-related macular degeneration

  Subhi, Y. & Sørensen, T. L., Nov 2016, In: Danish Medical Journal. 63, 11, p. 1-5 5 p., A5303.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Exercise 62%
  • Ocular Vision 40%
  • Sweat 28%
  • Visual Acuity 20%
  18 Citations (Scopus)

• Thickening of inner retinal layers in the parafovea after bariatric surgery in patients with type 2 diabetes

  Brynskov, T., Laugesen, C. S., Floyd, A. K. & Sørensen, T. L., 1 Nov 2016, In: Acta Ophthalmologica. 94, 7, p. 668–674 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Bariatric Surgery 100%
  • Retinal Artery 83%
  • Retinal Vessels 70%
  • Type 2 Diabetes Mellitus 67%
  • Multivariate Analysis 63%
  6 Citations (Scopus)
• 2015

  Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

  Modvig, S., Degn, M., Roed, H., Sørensen, T. L., Larsson, H., Langkilde, A., Fredriksen, J. L. & Sellebjerg, F., 1 Dec 2015, In: Multiple Sclerosis Journal. 21, 14, p. 1761-1770

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Chitinases 100%
  • Optic Neuritis 88%
  • Intermediate Filaments 76%
  • Multiple Sclerosis 61%
  • Cerebrospinal Fluid 60%
  76 Citations (Scopus)

• Early and exudative age-related macular degeneration is associated with increased plasma levels of soluble TNF receptor II

  Faber, C., Jehs, T., Juel, H. B., Singh, A., Falk, M. K., Sørensen, T. L. & Nissen, M. H., 1 May 2015, In: Acta Ophthalmologica. 93, 3, p. 242-47 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Tumor Necrosis Factor Receptors 100%
  • Macular Degeneration 91%
  • Complement Factor H 23%
  • Interleukin-15 22%
  • Interleukin-18 20%
  15 Citations (Scopus)

• EXPRESSION OF HLA-G IN THE RETINAL PIGMENT EPITHELIAL CELLS AND ITS IMPORTANCE FOR THE DEVELOPMENT OF AGE-RELATED MACULAR DEGENERATION

  Svendsen, S. G., Daouya, M., Wu, C-L., Faber, C., Falk, M. K., Singh, A., Sorensen, T. L., Hviid, T. V. F., Carosella, E. D., LeMaoult, J. & Nissen, M. H., Aug 2015, In: HLA. 86, 2, p. 76-77 2 p.

  Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

• Fysisk aktivitet gavner patienter med aldersrelateret maculadegeneration

  Translated title of the contribution: Physical activity benefits patients with age-related macular degenerationSubhi, Y., Munch, I. C., Singh, A. & Sørensen, T. L., 17 Aug 2015, In: Ugeskrift for Laeger. 177, 34, p. 1624-1627 4 p.

  Research output: Contribution to journal › Review › peer-review

  • Macular Degeneration 100%
  • Exercise 62%
  • Morbidity 14%
  • Sedentary Behavior 12%
  • Dietary Supplements 12%
  1 Citation (Scopus)

• Lærebog i Øjensygdomme

  Lund-Andersen, H., Sørensen, T. L., Mellerkær, P. & Villumsen, J., 22 Feb 2015, 1 ed. forlaget liva.

  Research output: Book/Report › Book › Education

• Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration

  Juel, H. B., Faber, C., Fog, L. M., Bastrup-Birk, S., Reese-Petersen, A. L., Falk, M. K., Singh, A., Sørensen, T. L., Garred, P. & Nissen, M. H., 15 Jul 2015, In: P L o S One. 10, 7, p. 1-12 e0132800.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • PTX3 protein 100%
  • macular degeneration 97%
  • Pigments 81%
  • Degeneration 71%
  • Macular Degeneration 68%
  9 Citations (Scopus)

• The association between Neovascular Age-related Macular Degeneration and Regulatory T cells in peripheral blood

  Madelung, C. F., Falk, M. & Sørensen, T. L., 25 Jun 2015, In: Clinical Ophthalmology (Online). 9, p. 1147—1154

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Regulatory T-Lymphocytes 94%
  • Fluorescein Angiography 22%
  • T-Lymphocyte Subsets 20%
  • Surface Antigens 20%
  7 Citations (Scopus)
• 2014

  Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case-control study

  Falk, M. K., Singh, A., Faber, C., Nissen, M. H., Hviid, T. & Sørensen, T. L., 27 Feb 2014, In: B M C Ophthalmology. 14, 1, p. 1-7 8 p., 22.

  Research output: Contribution to journal › Journal article › Research

  • Chemokine CCL11 100%
  • Chemokine Receptors 68%
  • Macular Degeneration 64%
  • Case-Control Studies 49%
  • CCR3 Receptors 17%
  11 Citations (Scopus)

• CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD

  Falk, M. K., Singh, A., Faber, C., Nissen, M. H., Hviid, T. & Sørensen, T. L., 15 Dec 2014, In: PLOS ONE. 9, 12, p. 1-15 15 p., e112473.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • chemokine receptors 100%
  • macular degeneration 94%
  • chemokines 84%
  • Receptor 81%
  • Chemokine Receptors 71%
  19 Citations (Scopus)

• Dysregulation of CXCR3 expression on peripheral blood leukocytes in patients with neovascular age-related macular degeneration

  Falk, M. K., Singh, A., Faber, C., Nissen, M. H., Hviid, T. & Sørensen, T. L., 8 May 2014, In: Investigative Ophthalmology & Visual Science. 55, 7, p. 4050-4056 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Leukocytes 75%
  • Choroidal Neovascularization 29%
  • Wet Macular Degeneration 23%
  • T-Lymphocytes 22%
  21 Citations (Scopus)

• Eight-and-a-half syndrome as presenting sign of childhood multiple sclerosis

  Mortzos, P., Nordling, M. M. & Sørensen, T. L., 1 Oct 2014, In: Journal of AAPOS. 18, 5, p. 490-492 3 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Multiple Sclerosis 100%
  8 Citations (Scopus)

• Foveal morphology affects self-perceived visual function and treatment response in age-related macular degeneration. A cohort study.

  Subhi, Y., Henningsen, G., Larsen, C. T., Sørensen, M. S. & Sørensen, T. L., 11 Mar 2014, In: P L o S One. 9, 3, p. 1-12 12 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • macular degeneration 100%
  • cohort studies 92%
  • Cohort Study 87%
  • Degeneration 73%
  • Macular Degeneration 70%
  19 Citations (Scopus)

• Fysisk aktivitet gavner patienter med aldersrelateret maculadegeneration

  Translated title of the contribution: Physical activity benefits patients with age-related macular degeneration.Subhi, Y., Munch, I. C., Singh, A. & Sørensen, T. L., 8 Sept 2014, In: Ugeskrift for Laeger. 176, p. 2-6 5 p., V12130712.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Exercise 62%
  • Morbidity 14%
  • Sedentary Behavior 12%
  • Dietary Supplements 12%

• Intravitreal ranibizumab for retinal vein occlusion through 1 year use in clinical practice.

  Brynskov, T., Kemp, H. & Sørensen, T. L., Aug 2014, In: Retina. 34, 8, p. 1637–1643 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  30 Citations (Scopus)

• Low awareness of the Charles Bonnet syndrome in patients attending a retinal clinic

  Singh, A., Subhi, Y. & Sørensen, T. L., Feb 2014, In: Danish Medical Journal. 61, 2, p. 1-4 4 p., A4770.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Charles Bonnet Syndrome 100%
  • Hallucinations 21%
  • Low Vision 16%
  • Visual Acuity 16%
  • Retina 11%
  6 Citations (Scopus)

• Visual Hallucinations in a Patient with Horner's Syndrome Secondary to Internal Carotid Dissection

  Singh, A., Mortzos, P. & Sørensen, T. L., 22 May 2014, In: Case Reports in Ophthalmology. 5, 3, p. 347-351 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Horner Syndrome 100%
  • Hallucinations 80%
  • Dissection 60%
  • Magnetic Resonance Angiography 40%
  • Cerebrum 39%
  3 Citations (Scopus)
• 2013

  Age-related macular degeneration is associated with increased proportion of CD56(+) T cells in peripheral blood

  Faber, C., Singh, A., Krüger Falk, M., Juel, H. B., Sørensen, T. L. & Nissen, M. H., Nov 2013, In: Ophthalmology. 120, 11, p. 2310-6 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • T-Lymphocytes 59%
  • Complement Factor H 47%
  • Cytomegalovirus 17%
  • Confidence Intervals 15%
  33 Citations (Scopus)

• Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment

  Falk, M. K., Kemp, H. & Sørensen, T. L., Jan 2013, In: American Journal of Ophthalmology. 155, 1, p. 89-95.e3

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Ranibizumab 100%
  • Macular Degeneration 78%
  • Therapeutics 12%
  • Diabetic Retinopathy 6%
  • Visual Acuity 4%
  68 Citations (Scopus)

• Increased Expression of CD200 on Circulating CD11b+ Monocytes in Patients with Neovascular Age-related Macular Degeneration

  Singh, A., Falk, M. K., Hviid, T. V. F. & Sørensen, T. L., May 2013, In: Ophthalmology, The American Academy of Ophthalmology.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Monocytes 79%
  • Granulocytes 23%
  • Eye 22%
  • Fibrosis 17%
  29 Citations (Scopus)

• In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels

  Subhi, Y., Singh, A., Falk, M. K. & Sørensen, T. L., 9 Dec 2013, In: Clinical ophthalmology (Auckland, N.Z.). 2014, 8, p. 15-21 7 p.

  Research output: Contribution to journal › Journal article › Research

  • Macular Degeneration 100%
  • C-Reactive Protein 84%
  • Exercise 62%
  • Visitors to Patients 16%
  • Inflammation 12%
  23 Citations (Scopus)

• Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting

  Brynskov, T., Laugesen, C. S. & Sørensen, T. L., May 2013, In: Acta Ophthalmologica.

  Research output: Contribution to journal › Journal article › Research › peer-review

  16 Citations (Scopus)

• Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants

  Brynskov, T., Laugesen, C. S., Halborg, J., Kemp, H. & Sørensen, T. L., 2013, In: Clinical Ophthalmology (Online). 7, p. 1171-4 4 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Edema 100%
  • Dexamethasone 79%
  • Intravitreal Injections 51%
  • Ranibizumab 43%
  • Diabetic Retinopathy 22%
  22 Citations (Scopus)

• NO CASES OF ENDOPHTHALMITIS AFTER 20,293 INTRAVITREAL INJECTIONS IN AN OPERATING ROOM SETTING

  Brynskov, T., Kemp, H. & Sørensen, T. L., 5 Dec 2013, In: Retina (Philadelphia, Pa.).

  Research output: Contribution to journal › Journal article › Research

  • Endophthalmitis 100%
  • Intravitreal Injections 96%
  • Operating Rooms 83%
  • University Hospitals 31%
  45 Citations (Scopus)

• The Association between Plasma 25-Hydroxyvitamin D and Subgroups in Age-Related Macular Degeneration: A Cross-Sectional Study

  Singh, A., Falk, M. K., Subhi, Y. & Sørensen, T. L., 29 Jul 2013, In: PLOS ONE. 8, 7, p. e70948

  Research output: Contribution to journal › Journal article › Research › peer-review

  • macular degeneration 100%
  • 25-hydroxyvitamin D 79%
  • cross-sectional studies 76%
  • Degeneration 73%
  • Plasma 72%
  26 Citations (Scopus)

• Visual loss, homonymous hemianopia, and unilateral optic neuropathy as the presenting symptoms of vertebrobasilar dolichoectasia

  Mortzos, P. & Sørensen, T. L., 2013, In: Case reports in ophthalmological medicine. 2013, p. 562397

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Vertebrobasilar Insufficiency 100%
  • Hemianopsia 95%
  • Optic Nerve Diseases 87%
  • Visual Pathways 29%
  • Cranial Nerves 27%
• 2012

  Altered expression of CD46 and CD59 on leukocytes in neovascular age-related macular degeneration.

  Singh, A., Faber, C., Falk, M., Nissen, M. H., Hviid, T. & Sørensen, T. L., Jul 2012, In: American Journal of Ophthalmology. 154, 1, p. 193-199

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Leukocytes 75%
  • Monocytes 22%
  • Case-Control Studies 21%
  • Fibrosis 20%
  39 Citations (Scopus)

• Effect of intravitreal ranibizumab in the treatment of peripapillary choroidal neovascularisation.

  Hamoudi, H. & Sørensen, T. L., 2012, In: J Ophthalmol. dec, 22, 4 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

• Identification of foreign bodies on the ocular surface after uneventful intravitreal injections.

  Jørgensen, J. S., Kemp, H. & Sørensen, T. L., Dec 2012, In: Acta Ophthalmologica. April , 4

  Research output: Contribution to journal › Journal article › Research › peer-review

  2 Citations (Scopus)

• Loss of retinal function and pigment epithelium changes in a patient with common variable immunodeficiency.

  Halborg, J. & Sørensen, T. L., 2012, In: Case Reports in Ophthalmological Medicine. 967561

  Research output: Contribution to journal › Journal article › Research › peer-review

• Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab.

  Eghøj, M. S. & Sørensen, T. L., Jan 2012, In: British Journal of Ophthalmology. 96, 1, p. 21-23

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Tachyphylaxis 100%
  • Ranibizumab 94%
  • Macular Degeneration 74%
  • Ocular Vision 19%
  • Choroidal Neovascularization 19%
  106 Citations (Scopus)
• 2011

  AMD som en inflammatorisk sygdom

  Sørensen, T. L., 2011, In: Oftalmolog. Dec, p. 18-21

  Research output: Contribution to journal › Journal article › Communication

• Authors' response

  Singh, A. & Sørensen, T. L., 1 Aug 2011, In: British Journal of Ophthalmology. 95, 8, p. 1174 1 p.

  Research output: Contribution to journal › Letter

• Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration.

  Singh, A. & Sørensen, T. L., Feb 2011, In: British Journal of Ophthalmology. 95, 2, p. 291-292

  Research output: Contribution to journal › Journal article › Research › peer-review

  18 Citations (Scopus)

• Charles Bonnet-syndrom og visuelle hallucinationer

  Singh, A. & Sørensen, T. L., 3 Jan 2011, In: Ugeskrift for Laeger. 173, 1, p. 47-49

  Research output: Contribution to journal › Journal article › Communication

  2 Citations (Scopus)

• Danish version of Visual Function Questionnaire-25 and its use in age-related macular degeneration.

  Sørensen, M. S., Andersen, S., Henningsen, G. Ø., Larsen, C. T. & Sørensen, T. L., Jun 2011, In: Danish Medical Bulletin. 58, 6, p. A4290 3 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Macular Degeneration 100%
  • Reproducibility of Results 28%
  • Eye Diseases 16%
  11 Citations (Scopus)

• Hallucinationer ved synsnedsættelse

  Singh, A. & Sørensen, T. L., 3 Jan 2011, In: Ugeskrift for Laeger. 173, 1, p. 50 1 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  1 Citation (Scopus)

• Ranibizumab treatment in patients with neovascular age-related macular degeneration and very low vision.

  Sørensen, T. L. & Kemp, H., Feb 2011, In: Acta Ophthalmologica. p. e97

  Research output: Contribution to journal › Journal article › Research › peer-review

  4 Citations (Scopus)

• The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovascular age-related macular degeneration.

  Singh, A. & Sørensen, T. L., 2011, In: British Journal of Ophthalmology. 172, 41, p. 291-292

  Research output: Contribution to journal › Journal article › Research › peer-review

• Visual function questionnaire-25 og anvendelse på patienter med aldersrelateret makuladegeneration

  Sørensen, M. S., Andersen, S., Henningsen, G. O., Larsen, C. T. & Sørensen, T. L., 1 Jun 2011, In: Ugeskrift for Laeger. 173, 25, p. 1795 1 p.

  Research output: Contribution to journal › Journal article › Research › peer-review
• 2010

  Intravitreal ranibizumab mod aldersrelateret makuladegeneration

  Translated title of the contribution: Intravitreal ranibizumab for age-related macular degenerationSørensen, T. L. & Kemp, H., 1 May 2010, In: Ugeskrift for Laeger. 172, 22

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Ranibizumab 100%
  • Macular Degeneration 78%
  • Visual Acuity 64%
  • Choroidal Effusions 21%
  • Choroidal Neovascularization 18%
  5 Citations (Scopus)

• Iritis, ptosis, and sequential severe loss of vision in a patient with essential thrombocytosis.

  Sørensen, T. L. & Mortzos, P., May 2010, In: Eye (London, 1880). 24, 5, p. 928

  Research output: Contribution to journal › Journal article › Research › peer-review

  4 Citations (Scopus)

• Sammenlimning af begge øjne skal ikke behandles konservativt

  Øgard, C., Kjærbo, H. & Sørensen, T. L., 1 Oct 2010, In: Ugeskrift for Laeger. 172, 41, p. 2846-2847 2 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  3 Citations (Scopus)
• 2009

  Social impairment due to extreme photophobia.

  Sørensen, T. L., Mortzos, P. & Øgard, C., 2009, In: Acta Paediatrica. 98, 11, p. 1707-1708

  Research output: Contribution to journal › Journal article › Research › peer-review

  1 Citation (Scopus)
• 2007

  Chemokine receptor CCR5 in interferon-treated multiple sclerosis

  Sellebjerg, F., Kristiansen, T. B., Wittenhagen, P., Garred, P., Eugen-Olsen, J., Frederiksen, J. L. & Sørensen, T. L., 2007, In: Acta Neurologica Scandinavica. 115, 6, p. 413-8 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Chemokine Receptors 100%
  • Interferons 81%
  • Multiple Sclerosis 78%
  • Monocytes 55%
  • Interferon-beta 51%
  14 Citations (Scopus)

• Chemokine receptor CCR5 in interferon-treated multiple sclerosis

  Sellebjerg, F., Kristiansen, T. B., Wittenhagen, P., Garred, P., Eugen-Olsen, J., Frederiksen, J. L. & Sørensen, T. L., Jun 2007, In: Acta Neurologica Scandinavica. 115, 6, p. 413-8 6 p.

  Research output: Contribution to journal › Journal article › Research

  • Interferon-beta 100%
  • Chemokine Receptors 96%
  • Interferons 79%
  • Multiple Sclerosis 76%
  • CCR Receptors 66%
  14 Citations (Scopus)
• 2005

  CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis

  Sellebjerg, F., Ross, C., Koch-Henriksen, N., Sørensen, P. S., Frederiksen, J. L., Bendtzen, K. & Sørensen, T. L., 1 Dec 2005, In: Multiple Sclerosis. 11, 6, p. 641-5 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • CD4 Lymphocyte Count 100%
  • Interferons 90%
  • Multiple Sclerosis 86%
  • T-Lymphocytes 60%
  • Interferon-beta 56%
  13 Citations (Scopus)